Novavax Inc (NVAX)

R&D Expense Growth

-25.95%

Quarterly · Period ending:

NVAX logo

NVAX R&D Expense Growth

Latest reported-25.95%
NVAX Quarterly R&D Growth (QoQ) (0.00% → -25.95%)
High-resolution chart · PNG

NVAX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-25.9542%
29.0581%
-24.7247%
26.5879%
-12.7101%
-14.795%
19.7513%
-18.4972%
15.394%
-43.7276%
55.0396%
-51.5986%
-11.18%
-4.1687%
-15.2637%
5.0575%
-24.4691%
-60.1765%
135.9061%
-28.4728%
-3.7096%
47.7249%
36.4219%
743.962%
106.2504%
-42.4185%
57.6541%
-38.8138%
-14.2531%
-18.2932%
5.0549%
-7.2202%
0.0629%
-10.357%
18.6207%
6.6195%
4.2731%
-26.3131%
-3.554%
-18.3671%
-5.8708%
-9.1577%
171.8881%
11.4807%
-3.2679%
-15.1074%
58.6711%
26.4242%
4.7114%
-11.0362%
16.9989%
29.3278%
14.3448%
0.2125%
47.1775%
23.551%
1.95%
683.4877%
-89.6137%
11.7299%
3.14%
12.6509%
-38.9327%
24.3875%
-29.9258%
-17.6261%
108.5426%
-0.774%
24.1678%
-27.2634%
-32.2357%
60.8736%
21.3351%
7.8045%
-26.9968%
34.3668%
14.5942%
14.5944%
9.9897%
-14.6428%
67.372%
54.4073%
13.3506%
-15.6863%
12.6841%
-20.7008%
-0.7088%
26.2815%
-59.6652%
29.936%
-8.1832%
-8.5244%
18.055%
43.0732%
-55.3485%
15.507%
8.9395%
13.6346%
47.3534%
-54.209%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.